XML 32 R26.htm IDEA: XBRL DOCUMENT v3.25.1
Basis of Presentation and Summary of Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2025
Basis of Presentation and Summary of Significant Accounting Policies  
Schedule of Concentration of Credit Risk in Accounts Receivable

The Company is potentially subject to concentrations of credit risk in accounts receivable as the following customer balances exceed 10% of accounts receivable in the consolidated balance sheet as March 31, 2025 and December 31, 2024.

 

As of March 31, 2025

 

 

As of December 31, 2024

 

 

Accounts Receivable

 

 

% of Total Accounts Receivable

 

 

Accounts Receivable

 

 

% of Total Accounts Receivable

 

Customer A

 

$

 

 

 

 

 

$

200,000

 

 

 

28

%

Customer B

 

$

98,864

 

 

 

14

%

 

$

144,590

 

 

 

20

%

Customer C

 

$

84,715

 

 

 

12

%

 

$

 

 

 

 

Schedule of Information from the Consolidated Statements of Operations and Comprehensive Loss

Select information from the consolidated statements of operations and comprehensive loss as of the three months ended March 31, 2025 and 2024 is as follows:

 

 

Revenues

 

 

Net Loss Before
Allocation to Noncontrolling Interest

 

 

 

Three Months Ended March 31,

 

 

Three Months Ended March 31,

 

Segment

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Specialist isotopes and related services

 

$

1,101,605

 

 

$

840,354

 

 

$

(6,389,533

)

 

$

(4,643,494

)

Nuclear fuels

 

 

 

 

 

 

 

 

(2,093,649

)

 

 

(2,079,007

)

Corporate

 

 

 

 

 

 

 

 

21,750

 

 

 

(242,343

)

 

$

1,101,605

 

 

$

840,354

 

 

$

(8,461,432

)

 

$

(6,964,844

)

 

Schedule of Liabilities Measured as Level 3 at Fair Value on a Recurring Basis The following table provides a reconciliation of the Company’s liabilities measured as a Level 3 at fair value on a recurring basis using significant unobservable inputs:

 

 

Convertible
Notes Payable

 

 

Share
Liability

 

Balance as of December 31, 2023

 

$

 

 

$

140,455

 

Fair value at issuance

 

 

26,558,143

 

 

 

669,700

 

Fair value adjustment

 

 

6,875,041

 

 

 

194,540

 

Settlement of liability

 

 

 

 

 

(1,004,695

)

Balance as of December 31, 2024

 

 

33,433,184

 

 

 

 

Fair value of additional liability

 

 

 

 

 

247,000

 

Fair value adjustment

 

 

957,408

 

 

 

(12,500

)

Balance as of March 31, 2025

 

$

34,390,592

 

 

$

234,500